Professional Documents
Culture Documents
Department of Physics, Annamalai University, Annamalai Nagar 608 002, Tamil Nadu, India
Department of Biochemistry and Biotechnology, Annamalai University, Annamalai Nagar 608 002, Tamil Nadu, India
h i g h l i g h t s
g r a p h i c a l a b s t r a c t
a r t i c l e
i n f o
Article history:
Received 19 November 2012
Received in revised form 14 February 2013
Accepted 4 March 2013
Available online 21 March 2013
Keywords:
FTIR
Liver
Aluminium
ICP-OES
a b s t r a c t
In this study, we made a new approach to evaluate aluminium induced metabolic changes in liver tissue of
mice using Fourier transform infrared spectroscopy analysis taking one step further in correlation with
strong biochemical evidence. This nding reveals the alterations on the major biochemical constituents,
such as lipids, proteins, nucleic acids and glycogen of the liver tissues of mice. The peak area value of amide
A signicantly decrease from 288.278 3.121 to 189.872 2.012 between control and aluminium treated
liver tissue respectively. Amide I and amide II peak area value also decrease from 40.749 2.052 to
21.170 1.311 and 13.167 1.441 to 8.953 0.548 in aluminium treated liver tissue respectively. This
result suggests an alteration in the protein prole. The absence of olenic@CH stretching band and C@O
stretching of triglycerides in aluminium treated liver suggests an altered lipid levels due to aluminium
exposure. Signicant shift in the peak position of glycogen may be the interruption of aluminium in the
calcium metabolism and the reduced level of calcium. The overall ndings exhibit that the liver metabolic
program is altered through increasing the structural modication in proteins, triglycerides and quantitative alteration in proteins, lipids, and glycogen. All the above mentioned modications were protected in
desferrioxamine treated mice. Histopathological results also revealed impairment of aluminium induced
alterations in liver tissue. The results of the FTIR study were found to be in agreement with biochemical
studies and which demonstrate FTIR can be used successfully to indicate the molecular level changes.
2013 Elsevier B.V. All rights reserved.
Introduction
Aluminium (Al) is the third most prevalent element and the
most abundant metal in the earths crust, i.e., approximately 8%
Corresponding author. Tel.: +91 9865043811.
E-mail address: girihari777@yahoo.com (S. Sivakumar).
1386-1425/$ - see front matter 2013 Elsevier B.V. All rights reserved.
http://dx.doi.org/10.1016/j.saa.2013.03.056
242
S. Sivakumar et al. / Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 110 (2013) 241248
liver and kidney [4,5]. Aluminium exposure also results in the production of free radicals [6]. ROS are highly toxic and can react with
lipids, proteins and nucleic acids, and lead to cell death via apoptosis or necrosis [7]. Al accumulation in liver induces oxidative stress
with an increase in thiobarbituric acid-reactive substances (TBARS)
and to a decrease in the levels of antioxidant defences, including
reduced glutathione (GSH) and the antioxidant enzymes, catalase
(CAT) and glutathione peroxidase (GSH-Px) [8]. Al exposure can result in Al accumulation in the liver leading to a disturbance of lipid
metabolism and an elevation of serum cholesterol [9]. Aluminium
induces cholestasis associated with multiple alterations in hepatocellular transporters involved in bile secretory function, like Mrp2
[10]. Al exposure has an adverse effect on essential elements in
humans, with subsequent impact on the cellular enzymatic and
metabolic processes [11]. Inductively Couple Plasma Optical Emission Spectroscopy (ICP-OES) is an important technique to study the
trace elements at molecular level in various biological samples. It is
particularly effective in this context due to its high sensitivity for
detecting the major trace elements [12].
For the last several decades the most widely used chelator in
the treatment of aluminium intoxication has been desferrioxamine
(DFO) [13]. The treatment commonly used in aluminium disorders
is desferrioxamine (DFO), which is a chelator with great capacity to
decrease Al body burden by increase its excretion in the urine. This
compound is usually employed in iron accumulation and since
there are chemical and physical similarities among aluminium
and iron (charge, ionic radius and protein binding) it has been used
in cases of aluminium accumulation [14].
Fourier transform infrared spectroscopy (FTIR) is one of the
most important metabolomic tools showing the molecular changes
that occur during a pathological condition. IR spectroscopy can distinguish differences in the characteristics of diverse molecules by
probing chemical bond vibrations and use these molecular and
sub-molecular proles to dene and differentiate diseased and
healthy tissues [15]. The frequency shifts shows the molecular
alteration of macromolecules such as protein, lipid, carbohydrate,
and nucleic acid can be considered for analysis [16]. As such infrared spectroscopy is a very valuable tool for biochemical investigations [17]. Previously, 17-b Estradiol induced compositional,
structural and functional changes in rainbow trout liver has been
investigated using FTIR spectroscopy [18]. Therefore, the main
objective of this study was to use this molecular ngerprinting approach to investigate the effects of aluminium on metabolic alterations in liver tissues of mice.
Treatment schedule
Mice were randomly allocated in three different groups. Each
group contains 12 animals. Group I served as control and were
fed on standard animal chow and water ad libitum. Animals in
groups II & III were administered aluminium in the form of aluminium chloride (100 mg/kg b.wt./day) orally for a period of 12 weeks.
Following to 12 weeks of AlCl3 administration, group III mice were
treated with DFO (s.c.) at the dose of 0.89 mmol/kg for ve consecutive days. Aluminium chloride was dissolved in normal drinking
water and was given by an oral gavage. Twenty-four hours after
the last administration of the chelator, mice were anesthetized
with diethyl ether and killed. Six liver samples from each group
were immediately homogenized and used for the various biochemical estimations. For FTIR analysis six whole liver samples of all
three groups were freeze dried and homogenized with liquid nitrogen using agate mortar and pestle. Samples were stored under
80 C until used. Even though samples in dried form reduced
the interference of water, it has some limitations. The bands become much broader in the dry sample, leading to the disappearance of the ne structure observed in the wet sample and the
dry sample method is not suitable for characterize the living cells.
FTIR sample preparation
For FTIR analysis, the samples were mixed with KBr at ratio of
1:100. The mixture was then subjected to a pressure of 1100 kg/
cm2 to produce KBr pellets for use in FTIR Spectrometer. Pellets
of the same thickness were equipped by taking the same quantity
of sample and applying the same pressure. Therefore, in the current study, it was possible to directly relate the intensities of the
absorption bands to the quantity of the corresponding functional
groups.
FTIR spectra and data analysis
FTIR spectra of the region 4000400 cm 1 were recorded at the
temperature of 25 1 C on a Nicolet-Avatar-360 FTIR Spectrometer equipped with an air-cooled DTGS (deuterated triglycine
sulfate) and purged with nitrogen. Each sample was scanned with
three different pellets under identical conditions. These replicates
were averaged and then used. The spectra were analyzed using
ORIGIN 6.0 software (OriginLab Corporation, Massachusetts, USA).
ICP-OES analysis
S. Sivakumar et al. / Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 110 (2013) 241248
243
244
S. Sivakumar et al. / Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 110 (2013) 241248
Fig. 1. FT-IR spectra of the control, aluminium intoxicated and DFO treated liver tissue of mice.
Table 1
FT-IR vibrational assignment for control, aluminium intoxicated and DFO treated liver tissue of mice.
Wavenumber (cm
Control
Aluminium
treated
Aluminium + DFO
treated
3419
3417
3415
3012
2958
2923
2854
1740
1654
1542
1457
1398
1234
1163
1082
1048
970
Not observed
2959
2925
2854
Not observed
1654
1542
1456
1396
1237
1159
1083
1045
968
3016
2959
2926
2853
Not observed
1652
1543
1456
1396
1236
1164
1083
1049
971
Amide A: mainly NAH stretching of proteins with the little contribution from OAH stretching of
polysaccharides.
olenic@CH stretching, unsaturated fatty acids.
CH3 asymmetric stretch: mainly lipids
CH2 asymmetric stretch: mainly lipids
CH2 symmetric stretching lipids (fatty acids)
Ester C@O stretch: triglycerides, cholesterol esters
Amide I: C@O stretching of proteins
Amide II: NAH bending and CAN stretching of proteins
CH2 Bending: mainly lipids, with the little contribution from proteins
COO symmetric stretch: fatty acids and amino acids
PO2 asymmetric stretch: mainly nucleic acids with the little contribution from phospholipids
COAOAC asymmetric stretching: glycogen and nucleic acids
PO2 symmetric stretch: nucleic acids and phospholipids
CAO stretching: polysaccharides
CAN+AC symmetric stretch: nucleic acids
in the polysaccharides metabolism and the peak area value also decreased in aluminium intoxicated group. The band centered at
970 cm 1 is generally assigned to symmetric stretching mode of
dianionic phosphate monoester of cellular nucleic acids, especially
for DNA.
ICP-OES analysis
The elements such as Ca, Fe, Cu, Mn and Zn are essential elements
because of their important role in biological systems. Aluminium
may interfere with various metabolic processes, in which Ca2+,
Mg2+, Fe3+ and Fe2+ (gastrointestinal absorption) are involved [38].
ICP-OES results show the interaction of aluminium with essential
elements in Table 4. The choice of those elements was based in previous studies which showed potential relationship between aluminium and the above mentioned elements [39]. In the present study
the intoxicated mice showed a reduction in the level of calcium, further the administration of DFO also not shown any increment in the
level of calcium. Tissue concentration of other elements level did not
show any signicant difference except Calcium.
S. Sivakumar et al. / Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 110 (2013) 241248
245
Fig. 2. Selected wavenumber regions of control, aluminium intoxicated and DFO treated liver tissue of mice in the range of 38002700 cm1 (A); 18001400 cm1 (B); 1400
400 cm1 (C).
Table 2
Wave number alterations of major macromolecular groups.
Molecular vibration
Control
Aluminium treated
3419.14 2.14
3012.17 0.32a
1740.10 0.12a
1234.22 1.08a
1048.31 0.21a
1163.64 0.19a
3417.19 2.11
Not observed
Not observed
1237.13 0.52
1045.13 0.12
1159.29 0.31
3415.21 2.18
3016.12 0.09a
Not observed
1236.38 0.16
1049.16 0.19a
1164.12 0.22a
Values are expressed as mean S.D. for six mice in each group.
a
The frequency values are shifted signicantly compared with aluminium treated (P < 0.05) animal Liver spectra.
246
S. Sivakumar et al. / Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 110 (2013) 241248
Table 3
Band area variations of macromolecular groups from quantitative analysis of spectra.
Table 7
Levels of Non-enzymic antioxidants in control and experimental mice.
Wavenumber
(cm 1)
Control
Aluminium
treated
Aluminium + DFO
treated
Groups
GSH (mg/100
g tissue)
Vitamin C
(lg/mg protein)
Vitamin E
(lg/mg protein)
3419
3012
2958
2923
2854
1740
1654
1542
1457
1398
1234
1163
1082
1047
970
288.278 3.121a
0.213 0.615a
0.713 0.142a
4.563 0.579a
1.355 0.462a
0.360 0.082a
40.749 2.052a
13.167 1.441a
2.393 0.397a
4.826 1.273a
5.690 1.181a
0.312 0.038a
1.087 0.237a
0.408 0.035a
0.091 0.008a
189.872 2.012
0.438 0.235
2.007 1.470
0.941 0.615
21.170 1.311
8.953 0.548
1.056 0.085
1.354 0.179
2.157 0.394
0.214 0.725
0.684 0.647
0.173 0.065
0.047 0.036
231.449 3.448a
0.353 0.067a
0.575 0.064a
2.315 1.147
0.802 0.624
35.813 1.965a
10.984 0.704a
1.468 0.009a
3.609 0.581a
3.515 0.168a
0.256 0.048
0.643 0.241
0.080 0.009
0.096 0.021a
Control
Al
Al + DFO
93.50 5.26
60.82 5.60a
85.63 6.27b
1.86 0.16
0.74 0.92a
1.32 0.40b
4.84 0.72
2.31 0.25a
3.91 0.17b
Values are expressed as mean S.D. for six mice in each group.
a
The band area values are shifted signicantly compared with aluminium treated (P < 0.05) animal Liver spectra.
Table 4
concentrations of essential elements in liver tissue of control, aluminium intoxicated
and DFO treated mice (lg/g tissue).
Groups
Calcium
Magnesium
Zinc
Copper
Iron
Control
Al
Al + DFO
92 5.7
76 8.3a
78 9.7a
194 34.5
190 29.4
188 22.1
26 3.6
25 4.4
24 3.7
4.8 1.1
5.2 0.8
5.5 0.9
208 31.5
216 36.9
222 43.4
Values are expressed as mean S.D. for six mice in each group.
a
Signicant as compared to control (P < 0.05).
Table 5
Effect of DFO on protein lipid peroxidation product and enzymatic antioxidants in
aluminium intoxicated mice.
Parameters
Control
Al intoxicated
Al + DFO
35.13 0.29
1.95 0.09
0.95 0.12
6.45 0.31
52.76 5.42
20.52 0.22a
4.62 0.48a
3.92 0.25a
3.98 0.37a
28.51 4.31a
26.61 0.35b
2.87 0.71b
1.86 0.15b
4.83 0.42b
41.74 6.33b
11.54 1.61
6.91 1.25a
9.62 0.95b
Values are expressed as mean S.D. for six mice in each group.
a
Signicant as compared to control (P < 0.05).
b
Signicant as compared to Al intoxicated (P < 0.05).
Table 6
Effect of DFO on changes in the serum AST, ALT and ALP of aluminium intoxicated
mice.
Groups
AST (IU/L)
ALP (IU/L)
ALT (IU/L)
Bilirubin (mg/
dl)
Control
Al
Al + DFO
73.50 5.26
109.10 8.10a
89.63 6.27b
70.36 5.61
101.04 8.50a
83.70 6.30b
32.88 2.70
61.91 4.60a
41.92 2.78b
0.57 0.03
1.20 0.90a
0.83 0.11b
Values are expressed as mean S.D. for six mice in each group.
a
Signicant as compared to control (P < 0.05).
b
Signicant as compared to Al intoxicated (P < 0.05).
(P < 0.05) decreased activities of serum AST, ALT, ALP, and bilirubin.
The levels of nonenzymic antioxidants (vitamin C, vitamin E, and
GSH) in the control and experimental mice liver are presented in
Table 7. GSH is involved in the mechanism of detoxication scav-
Values are expressed as mean S.D. for six mice in each group.
a
Signicant as compared to control (P < 0.05).
b
Signicant as compared to Al intoxicated (P < 0.05).
enging free radicals in rat liver [43]. Vitamins C and E were studied
to minimize Al toxicity [44]. The levels of vitamins C and E and GSH
were signicantly (P < 0.05) reduced in Al-treated mice when compared to control mice. Administration of DFO signicantly
(P < 0.05) increased the levels of nonenzymic antioxidants in Aladministered mice liver.
Fig. 3AC shows the control, aluminium intoxicated and effect
of DFO on the histology of liver tissue in aluminium intoxicated
mice, respectively. Control liver shows normal hepatic parenchyma
(Fig. 3A). Fig. 3B shows the histopathological nding of aluminium
intoxicated liver with diffused fatty change. In Fig. 3C, Al + DFO
administrated liver shows proliferative hepatocytes.
Discussion
Al exposure has a most important, damaging impact on hepatocellular integrity and function. The liver has facilitated specic
transport systems for Al uptake, and similar to other organs that
accumulate Al, it is not surprising that the liver is a target for Al
toxicity [9]. FTIR spectroscopy could be a convenient tool for monitoring metabolic changes in liver tissue after in vivo exposure to
chemical drugs, and that it might be used in conjunction with biochemical and physiological data [45]. In this study, we examined
the effects of DFO on aluminium induced changes in mice liver tissue at molecular level using FT-IR spectroscopy. The FTIR analysis
explores the vibration of functional groups present in macromolecules and shows the molecular structural changes of the molecules
through shifts in wavenumbers. The signal intensity, or more accurately, the band area gives information about the concentration of
related functional groups [33]. So in this study, the decreased
intensity of amide A band in the aluminium intoxicated liver tissue
reects the decreased quantity of protein. This decreased quantity
indicates the damage of amide linkage in aluminium intoxicated liver tissue. As can be seen from Table 5, there was an increment in
the level of thiobarbituric acid reactive substances and lipid hydroperoxides. Oxidative stress occurs when ROS levels exceed the
antioxidant capacity of a cell. Al generates reactive oxygen species,
resulting in oxidative deterioration of lipids, proteins and DNA.
Makrides [46] suggested that free radical damage can cause a
reduction in protein synthesis. The decreased antioxidant activities
could bedue to the induction of lipid peroxidation [47]. Tables 5
and 6 show the depletion of enzymic and non enzymic antioxidants level in aluminium intoxicated liver tissue. So the reduction
of protein quantity may be the imbalance between oxidants and
antioxidants. DFO is also a useful therapeutic tool in blocking
ROS production [48]. In this study the administration of DFO bring
back the protein level near to control value.
ROS may attack any type of molecules, but their main target appears to be polyunsaturated fatty acids (PUFAs), the precursors of
lipid peroxide formation [49]. It is known that unsaturated lipids
are more prone to lipid peroxidation [50]. Unsaturated lipids are
highly vulnerable to oxidative attack because of their double bond
content. FT-IR is usefulness in monitoring unsaturated lipid content by utilizing the olenic @CH stretching mode 3012 cm 1
S. Sivakumar et al. / Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 110 (2013) 241248
247
Fig. 3. Representative photomicrograph of histological changes in liver. (A) Control, normal hepatic parenchyma. (B) Aluminium intoxicated, there was diffused fatty change.
(C) Al + DFO, shows proliferative hepatocytes.
Table 8
Band area ratio for selected bands of liver tissues of mice.
Band area ratio
Control
Aluminium treated
Aluminium
+ DFO treated
I2959/I2854
I1082/I1542
I2923/I2958
0.526 0.013
0.082 0.004
6.399 0.166
0.465 0.016*
0.076 0.003
4.582 0.142
0.716 0.020
0.058 0.003
4.026 0.138
Values are shown as mean standard error; the degree of signicance was denoted
as:
P < 0.001.
*
P < 0.01.
248
S. Sivakumar et al. / Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 110 (2013) 241248
in the calcium metabolism may also be the reason for the changes
in the glycogen peak position.
At the molecular level, any effects of Al would be most likely to
involve DNA damage. Al does have a genotoxic prole and has been
shown to bind to DNA [61]. The band centered at 970 cm 1 is generally assigned to cellular nucleic acids, especially for DNA. The
stronger nucleic acid band implied an increase in the relative content of the nucleic acids in the treated tissues [62]. In this study the
peak area of nucleic acid decreased in aluminium intoxicated liver
tissue of mice. This indicates the decline in the relative content of
the nucleic acids and the deleterious effect of aluminium in DNA.
Conclusion
The present studies demonstrate FTIR spectra reveals signicant
changes in absorbance intensities between the control and aluminium intoxicated liver tissues. Further, the administration of DFO
considerably recover the levels of biochemical constituents. The
experimental results suggest that quantity of protein signicantly
decreased due to the imbalance between oxidants and antioxidants. Quantity of unsaturated fatty acid decreased may indicate
the increases of lipid peroxidation. Interaction of aluminium with
ATP metabolism and calcium homeostasis has been articulate
through the Shift in the peak position and the decreased level of
glycogen in aluminium intoxicated liver tissue. In addition FTIR results were found to be in agreement with biochemical studies. Finally the present study shows that the FTIR spectroscopy is likely
to be a very informative technique to determine the aluminium
toxicity induced changes in liver tissue at molecular level.
Acknowledgment
The nancial support to Mr. J. Sivasubramanian as project fellow from the University Grants Commission, New Delhi, India is
gratefully acknowledged.
References
[1]
[2]
[3]
[4]
[5]
[6]
[7]
[8]
[9]
[10]
[11]
[12]
[13]
[14]
[15] A. Hynes, D.A. Scott, A. Man, D.L. Singer, M.G. Sowa, K.Z. Liu, BMC Med. Imag.
(2005). 5:2 doi:10.1186/1471-2342-5-2.
[16] N. Toyran, F. Zorlu, G. Donmez, K. Ode, F. Severcan, Eur. Biophys. J. 33 (2004)
549554.
[17] F. Le Naour, M.P. Bralet, D. Debois, C. Sandt, C. Guettier, PLoS ONE 4 (10) (2009)
e7408, http://dx.doi.org/10.1371/journal.pone.0007408.
[18] G. Cakmak, I. Togan, F. Severcan, Aquat. Toxicol. 77 (2006) 5363.
[19] G. Topping, Aquaculture 1 (1973) 141379.
[20] W.G. Niehius, D. Samuelsson, Eur. J. Biochem. 6 (1968) 126130.
[21] O.H. Lowry, N.J. Rosebrough, A.L. Farr, R.J. Randall, J. Biochem. (Tokyo) 193
(1951) 265275.
[22] Z.Y. Jiang, J.V. Hunt, S.P. Wolff, Anal. Biochem. 202 (1992) 384387.
[23] P.S. Kakkar, B.B. Das, P.N. Viswanathan, Ind. J. Biochem. Biophys. 21 (1984)
130132.
[24] K.A. Sinha, Anal. Biochem. 47 (1972) 8994.
[25] J.T. Rotruck, A.L. Pope, H.E. Ganther, A.B. Swanson, D.G. Haseman, W.G.
Hoekstra, Science 179 (1973) 588590.
[26] S. Reitman, S. Franke, Am. J. Clin. Pathol. 28 (1957) 5663.
[27] P.R.N. Kind, E. J King, J. Clin. Path. 7 (1954) 322326.
[28] H.T. Malloy, K.A. Evelyn, J. Bio. Chem. 119 (1937) 481490.
[29] G.L. Ellman, Arch. Biochem. Biophys. 82 (1959) 7077.
[30] H.J. Roe, C.A. Kuether, J. Biol. Chem. 147 (1943) 399407.
[31] H. Baker, O. Frank, B.D. Angelis, S. Feingold, Nutr. Rep. Int. 21 (1980) 531536.
[32] N.G. Jamin, P. Dumas, J. Moncuit, W.H. Fridman, J.L. Teillaud, G.L. Carr, G.P.
Williams, Proc. Natl. Acad. Sci. USA, Appl. Biol. Sci. 95 (1998) 48374840.
[33] F. Severcan, G. Gorgulu, S.T. Gorgulu, T. Guray, Anal. Biochem. 339 (2005) 36
40.
[34] G. Cakmak, I. Togan, C. Uguz, F. Severcan, Appl. Spectrosc. 57 (2003) 835841.
[35] G. Voortman, J. Gerrits, M. Altavilla, M. Henning, L. Van Bergeijk, J. Hessels,
Clin. Chem. Lab. Med. 40 (2002) 795798.
[36] M. Saravanakumar, J. Manivannan, J. Sivasubramanian, T. Silambarasan, E.
Balamurugan, B. Raja, Mol. Cell. Biochem. 362 (2012) 203209.
[37] D.J. Lyman, J.M. Wijelath, Biomed. Mater. Res. (Appl. Biomater.) 48 (1999)
172186.
[38] P. Zatta, T. Kiss, M. Suwalsky, G. Berthon, Coordin. Chem. Rev. 228 (2002) 271
284.
[39] J.S. Domhnec, M. Gomez, J.M. Llobet, J. Corbella, J.L. Domingo, Pharmacol.
Toxicol. 80 (1997) 1117.
[40] Y.H. Yeh, Y.T. Lee, H.S. Hsieh, D.F. Hwang, Eur. J. Clin. Nutr. Metab. 4 (2009)
e187e192.
[41] S.J.S. Flora, M. Dhawan, S.K. Tandon, Hum. Exp. Toxicol. 10 (1991) 4548.
[42] H. Trkez, I.M. Yousef, F. Geyikoglu, Food. Chem. Toxicol. 48 (2010) 2741
2746.
[43] A. Meister, M.E. Anderson, Annu. Rev. Biochem. 52 (1983) 711760.
[44] M.I. Yousef, A.F. Salama, Food Chem. Toxicol. 47 (2009) 11681175.
[45] A.M. Melin, A. Perromat, G. Deleris, Biopolymers (Biospectroscopy) 57 (2000)
160168.
[46] S.C. Makrides, Biol. Rev. 58 (1983) 43422.
[47] G.C. Jagetia, G.K. Rajanikant, S.K. Rao, M.S. Baliga, Clin. Chim. Acta 332 (2003)
111121.
[48] L.R. Guelman, Neurotoxicol. Teratol. 26 (2004) 477483.
[49] J.M.C. Gutteridge, Int. J. Biochem. 14 (7) (1982) 649653.
[50] B. Halliwell, S. Chirico, Am. J. Clin. Nutr. 57 (1993) 715725.
[51] R.H. Sills, D.J. Moore, R. Mendelsohn, Anal. Biochem. 218 (1994) 118123.
[52] H. Takahashi, S.M. French, P.T.T. Wong, Clin. Exp. Res. 15 (1991) 219223.
[53] P. Dumas, N. Jamin, J.L. Teillaud, L.M. Miller, B. Beccard, Faraday D 126 (2004)
289301.
[54] N. Siegel, Am. J. Kidney Dis. 6 (5) (1985) 353357.
[55] V.S. Silva, A.I. Duarte, A.C. Rego, C.R. Oliveira, P.P. Goncalves, Toxicol. Sci. 88
(2005) 485494.
[56] L.P. Solheim, H.J. Formm, Anal. Biochem. 109 (1980) 266269.
[57] W.M. Sayed, M.A. Al Kahtani, A.M. Abdel Moneim, J. Hazard. Mater. 192 (2011)
880886.
[58] T. Kristin, Cell Calcium 36 (2004) 221233.
[59] T. Kawano, T. Kadono, T. Furuichi, S. Muto, F. Lapeyric, Biochem. Biophys. Res.
Commun. 308 (2003) 3542.
[60] E. Hashimoto, K. Mizuta, A. Tsutou, S. Nakamura, H. Yamamura, J. Biochem. 93
(1983) 939942.
[61] W.J. Lukiw, Aluminium and Alzheimers disease, in: C. Exley (Ed.), The Science
that Describes the Link, Elsevier, London, 2001, pp. 147168.
[62] Y.X. Ci, T.Y. Gao, J. Feng, Z.Q. Guo, Appl. Spectrosc. 53 (1999) 312315.